Oral cysteamine as an adjunct treatment in cystic fibrosis pulmonary exacerbations: An exploratory randomized clinical trial

BACKGROUND: Emerging data suggests a possible role for cysteamine as an adjunct treatment for pulmonary exacerbations of cystic fibrosis (CF) that continue to be a major clinical challenge. There are no studies investigating the use of cysteamine in pulmonary exacerbations of CF. This exploratory ra...

Descripción completa

Detalles Bibliográficos
Autores principales: Devereux, Graham, Wrolstad, Danielle, Bourke, Stephen J., Daines, Cori L., Doe, Simon, Dougherty, Ryan, Franco, Rose, Innes, Alastair, Kopp, Benjamin T., Lascano, Jorge, Layish, Daniel, MacGregor, Gordon, Murray, Lorna, Peckham, Daniel, Lucidi, Vincenzina, Lovie, Emma, Robertson, Jennifer, Fraser-Pitt, Douglas J., O'Neil, Deborah A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7769283/
https://www.ncbi.nlm.nih.gov/pubmed/33370348
http://dx.doi.org/10.1371/journal.pone.0242945

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7769283/
https://www.ncbi.nlm.nih.gov/pubmed/33370348
http://dx.doi.org/10.1371/journal.pone.0242945

Ejemplares similares